Trials / Completed
CompletedNCT01033383
Dosing Study of Cranberry Capsules for the Prevention of Bacteriuria in Nursing Home Residents
Pilot Study: Dosing Study of Cranberry Capsules for the Prevention of Bacteriuria in Nursing Home Residents
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Yale University · Academic / Other
- Sex
- Female
- Age
- 65 Years
- Healthy volunteers
- Accepted
Summary
This study will investigate whether there is a particular dose of cranberry capsules that is effective in preventing the occurrence of urinary tract infections in females at least 65 years of age or older who live in a nursing home and who have a history of urinary tract infections. The Yale research team will be enrolling 80 subjects in total over several nursing home locations within Connecticut.
Detailed description
Each subject was enrolled after providing a baseline urine specimen. Cranberry/placebo capsules were consumed for 30 days. Urine specimens were obtained weekly for 4 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Placebo | 36 milligram (mg) placebo capsule taken before quiet hours of sleep (qhs). |
| DIETARY_SUPPLEMENT | Cranberry Capsule | 36 milligram (mg) cranberry capsule, taken before quiet hours of sleep (qhs). |
Timeline
- Start date
- 2009-12-01
- Primary completion
- 2010-10-01
- Completion
- 2010-12-01
- First posted
- 2009-12-16
- Last updated
- 2013-08-15
- Results posted
- 2013-08-15
Locations
14 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01033383. Inclusion in this directory is not an endorsement.